Adalimumab alleviates skin pain in patients with moderate-to-severe hidradenitis suppurativa: Secondary efficacy results from the PIONEER I and PIONEER II randomized controlled trials

J Am Acad Dermatol. 2018 Dec;79(6):1141-1143. doi: 10.1016/j.jaad.2018.05.015. Epub 2018 May 19.
No abstract available

Publication types

  • Comparative Study

MeSH terms

  • Adalimumab / therapeutic use*
  • Adult
  • Double-Blind Method
  • Female
  • Hidradenitis Suppurativa / complications
  • Hidradenitis Suppurativa / drug therapy*
  • Humans
  • Male
  • Pain / drug therapy*
  • Pain Measurement
  • Randomized Controlled Trials as Topic

Substances

  • Adalimumab